The following table summarizes the changes in the carrying amounts of goodwill (in thousands):


	Carrying Amount
Balance - December 31, 2025:	$	1,015
Translation adjustment		(16	)
Balance - June 30, 2026:	$	999

As of December 31, 2025, the Company performed its annual goodwill impairment analysis following the steps laid out in ASC 350-20-35-3C. The Company's annual impairment analysis included a qualitative assessment to determine if it was necessary to perform the quantitative impairment test. The Company determined that there were certain triggering events, including sales declines, macroeconomic headwinds, regulatory headwinds and liquidity concerns. However, the fair value of the reporting unit was higher than its carrying amount. As such, the Company did not record any goodwill impairment charge for the year ended December 31, 2025. These triggering events remained during the three and six months ended June 30, 2026. However, the fair value of the reporting unit was higher than its carrying amount. As such, the Company did not record any goodwill impairment charge during the three and six months ended June 30, 2026. The Company's annual impairment testing date is December 31 of each year.

The following table summarizes the intangible assets and the related accumulated amortization (in thousands):


	June 30, 2026			December 31, 2025
Gross carrying amount	$	116		$	116
Accumulated amortization		(58	)		(46	)
Translation adjustment		4			6
Net carrying amount	$	62		$	76

Changes in the carrying amounts of intangible assets are summarized below (in thousands):


	Trade names			Customer relationships			Total
Balance - December 31, 2025:	$	34		$	42		$	76
Amortization		(6	)		(6	)		(12	)
Translation adjustments		(1	)		(1	)		(2	)
Balance - June 30, 2026:	$	27		$	35		$	62

The Company did not incur costs to renew or extend the term of acquired intangible assets for the three and six months ended June 30, 2026 and 2025. The estimated amortization expense for the Company's intangible assets is not significant in any future individual fiscal year. No indicators of impairment were identified during the three and six months ended June 30, 2026.